在治疗中度至重度过敏喘时,经批准的生物制剂的比较有效性:系统性审查和网络元分析
Yuelu Li1,2, Huan Zong3,4, Mengying Fang3,4
1Department of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, China, liyuelu121@163.com.
International archives of allergy and immunology
|October 30, 2025
概括
在中度至重度过敏性喘患者中,Tezepelumab显著减少了恶化,并改善了肺功能. 这个网络的元分析表明,tezepelumab应该优先治疗.
科学领域:
- 肺部病理学 肺部病理学
- 临床免疫学临床免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 过敏性喘影响全球数百万人,需要有效的生物治疗.
- 生物学家为中度至重度过敏喘提供有针对性的治疗方法.
- 不同生物制剂的比较疗效仍然是一个关键的研究问题.
研究的目的:
- 为了比较各种生物药物治疗中度至重度过敏喘的疗效.
- 进行随机对照试验 (RCT) 的网络元分析 (NMA).
- 根据临床结果确定最有效的生物治疗方法.
主要方法:
- 在主要数据库 (Cochrane,Embase,PubMed,Web of Science) 进行系统的文献搜索.
- 包括19个RCT,涉及7449名患者.
- 使用Cochrane风险偏差2工具和Stata 18.0.0工具进行分析.
主要成果:
- 与安慰剂相比,tzepelumab,benralizumab,dupilumab和omalizumab可以减少喘恶化.
- 与奥马利祖马布相比,特泽佩卢马布在减少恶化方面表现出更高的疗效.
- 杜比卢马布和特泽佩卢马布改善了肺功能;杜比卢马布和奥马利祖马布改善了喘控制;奥马利祖马布改善了生活质量.
结论:
- 佩鲁马布在减少恶化和改善肺功能方面显示出显著的临床优势.
- 建议在治疗中度至重度过敏性喘时优先使用tzepelumab.
- 这个NMA为生物选择提供了有价值的比较疗效数据.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
01:26Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K